Sex: M
Vaccine: COVID19-2
Symptoms: Blood pressure measurement, COVID-19, Hypertension, Inappropriate schedule of product administration
Clinical narrative: 1st one: 04Feb2021 2nd dose: 26Oct2021 Next one: 04Mar2022 Next one: 01Apr2022; Calle reports his blood pressure was 160 over whatever and it was high; Caller reports her husband had Covid last August; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (Calle reports his blood pressure was 160 over whatever and it was high), COVID-19 (Caller reports her husband had Covid last August) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st one: 04Feb2021 2nd dose: 26Oct2021 Next one: 04Mar2022 Next one: 01Apr2022) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient workout for 2 hours in the morning and very healthy. Patient had no previous health conditions. Patient did not had any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant products included LOSARTAN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-Oct-2021, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2022, received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2022, received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2022, received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. In August 2022, the patient experienced COVID-19 (Caller reports her husband had Covid last August). In October 2022, the patient experienced HYPERTENSION (Calle reports his blood pressure was 160 over whatever and it was high). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st one: 04Feb2021 2nd dose: 26Oct2021 Next one: 04Mar2022 Next one: 01Apr2022). In August 2022, COVID-19 (Caller reports her husband had Covid last August) had resolved. At the time of the report, HYPERTENSION (Calle reports his blood pressure was 160 over whatever and it was high) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st one: 04Feb2021 2nd dose: 26Oct2021 Next one: 04Mar2022 Next one: 01Apr2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2022, Blood pressure measurement: 160 over whatever and it was high.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported as over 60 years old.   Patient receive all his vaccines at Pharmacy except the first two.  Treatment information was not provided.   This case was linked to MOD-2023-733106 (Patient Link).